Okay, let's tackle this question about the gene responsible for Fibrous Dysplasia. First, I need to recall what Fibrous Dysplasia is. It's a bone disorder where normal bone is replaced by fibrous tissue and immature bone. I think it's related to a genetic mutation, but which gene?

I remember that some bone disorders are caused by mutations in the GNAS gene. GNAS is involved in the G protein signaling pathway. Oh wait, there's also the RAS pathway genes, like HRAS, KRAS, NRAS. But Fibrous Dysplasia is usually a somatic mutation, right? So it's not inherited but occurs in the affected individual.

The correct gene here is likely GNAS. Because mutations in GNAS lead to constitutive activation of the Gs alpha subunit, which increases cAMP levels. This disrupts normal bone remodeling, leading to fibrous dysplasia. Also, GNAS mutations are associated with McCune-Albright syndrome, which includes fibrous dysplasia as one of the features.

Now, the other options. Let's say the options are A. FGFR1, B. RAS, C. GNAS, D. TP53. Then:

- FGFR1 is involved in other bone disorders like Apert syndrome or Crouzon syndrome. Not Fibrous Dysplasia.
- RAS genes (HRAS, KRAS, NRAS) are oncogenes, more related to cancers. Not the cause here.
- TP53 is the tumor suppressor gene, linked to Li-Fraumeni syndrome and various cancers. Not related.

The clinical pearl is that Fibrous Dysplasia is caused by a somatic mutation in GNAS, leading to overactive Gs alpha and increased cAMP. Remembering this helps differentiate it from other bone diseases. Also, McCune-Albright syndrome is a key association.

So the correct answer is C. GNAS.

**Core Concept**
Fibrous dysplasia is a benign bone lesion caused by somatic mutations in the **GNAS** gene, leading to constitutive activation of the Gsα subunit. This results in elevated cyclic AMP (cAMP) levels, disrupting normal bone remodeling.

**Why the Correct Answer is Right**
The **GNAS** gene encodes the Gsα subunit of the G protein-coupled receptor (GPCR) pathway. A somatic mutation (typically GNAS p.Arg201Cys or p.Arg201His) causes uncontrolled Gsα signaling, increasing cAMP production. This dysregulates osteoblast differentiation and collagen synthesis, replacing normal bone with fibrous tissue and woven bone. The mutation is not inherited but occurs postzygotically, explaining the mosaic pattern of lesions.

**Why Each Wrong Option is Incorrect**
**Option A: FGFR1** – Mutations in fibroblast growth factor receptor 1 (FGFR1) cause craniosynostosis syndromes (e.g., Apert syndrome), not fibrous dysplasia.
**Option B: RAS** – RAS family mutations (HRAS, KRAS, NRAS) drive oncogenic signaling in cancers, unrelated to fibrous dysplasia’s pathogenesis.
**Option D: TP53** – TP53 mutations are linked to Li-Fraumeni

✓ Correct Answer: A. GNAS1